For example, up to 15% of breast tumors show discordance of HER2 status by FISH across randomly sampled sections, with heterogeneity being most frequent (up to 27%) in tumors with an equivocal (2 +) HER2 score [8]. This evidence concerns the gene ERBB2 and breast neoplasm.